Allergan vs ANI Pharmaceuticals
Allergan vs ANI Pharmaceuticals, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Allergan is on 19/100 and ANI Pharmaceuticals on 49/100.
Where each one leads
Allergan
- domain rating: 76/100 against 56/100
- funding raised: $30B against $671M
ANI Pharmaceuticals
- our overall score: 49/100 against 19/100
- agent readiness: 31/100 against 25/100
At a glance
| Measure | Allergan | ANI Pharmaceuticals |
|---|---|---|
| What it is | A global pharmaceutical company focused on developing and marketing innovative treatments. | Diversified biopharmaceutical company focused on rare diseases, generics, and established brands. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Pharmaceuticals, Rare Disease, Generics |
| Sells toBusiness model | B2B | B2C | B2B |
| Offering | Pharmaceuticals | Software | hardware | services | marketplace | platform |
| Founded | 1948 | 1996 |
| Headquarters | Dublin, Ireland | Baudette, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Allergan | ANI Pharmaceuticals |
|---|---|---|
| Employees | Not published | 707 |
| Headcount growthLast 12 months | Not published | +95.8% |
| Total funding | $30B | $671M |
| Latest round | Not published | Acquisition |
| LinkedIn followers | Not published | 31,660 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Allergan | ANI Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 19/100 | 49/100 |
| Traction | 40/100 | 60/100 |
| Team | Not published | 10/100 |
| Search visibility | 20/100 | 23/100 |
| Quality | 15/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (25/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 76/100 | 56/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Allergan | ANI Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| Frameworks | Tailwind CSS | Jquery, Bootstrap |
| Analytics | Not detected | Google Analytics 4 |
Allergan vs ANI Pharmaceuticals: common questions
Which is better, Allergan or ANI Pharmaceuticals?
On our 0-100 score ANI Pharmaceuticals rates higher (49/100 against 19/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Allergan and ANI Pharmaceuticals compare on the numbers?
Allergan leads on domain rating (76/100 against 56/100), funding raised ($30B against $671M). ANI Pharmaceuticals leads on our overall score (49/100 against 19/100), agent readiness (31/100 against 25/100).
Read the full Allergan review and pricing or the ANI Pharmaceuticals review and pricing. You can also browse other Allergan alternatives we track.